Table 1.
General characteristics of COVID-19 related AYUSH studies.
| Characteristics of study | Ayurveda (n = 113) | Yoga & Naturopathy (n = 12) | Unani (n = 7) | Siddha (n = 24) | Homeopathy (n = 23) | Others (n = 9) | Collaborative (n = 9) |
|---|---|---|---|---|---|---|---|
| Primary Aim | |||||||
| Observationsa (n = 6) | 2 | 0 | 0 | 4 | 0 | 0 | 0 |
| Prevention (n = 66) | 43 | 1 | 4 | 2 | 9 | 3 | 4 |
| Recovery (n = 112) | 66 | 1 | 3 | 18 | 14 | 6 | 4 |
| Mitigation of COVID-19 related stress (n = 11) | 1 | 10 | 0 | 0 | 0 | 0 | 0 |
| Both prevention & recovery (n = 2) | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| Study setting (Organization & Personnel) | |||||||
| AYUSH | 61 | 3 | 4 | 16 | 20 | 1 | 2 |
| Non-AYUSH | 49 | 8 | 2 | 6 | 3 | 8 | 7 |
| Both | 3 | 1 | 1 | 2 | 0 | 0 | 0 |
| Sponsorship | |||||||
| Government agencies & Institutions | 63 | 7 | 6 | 17 | 9 | 1 | 2 |
| Private clinics & Colleges | 23 | 5 | 0 | 4 | 14 | 2 | 4 |
| Pharmaceutical industry | 27 | 0 | 1 | 3 | 0 | 6 | 3 |
| Study sites | |||||||
| Single | 95 | 10 | 6 | 23 | 20 | 7 | 7 |
| Multi-centric | 18 | 2 | 1 | 1 | 3 | 2 | 2 |
| Inclusion criteria for age | |||||||
| <18 years | 3 | 0 | 1 | 0 | 1 | 0 | 0 |
| 18–60 Years | 36 | 5 | 0 | 8 | 2 | 3 | 2 |
| >60 years | 62 | 7 | 6 | 13 | 10 | 6 | 6 |
| Both<18 years to > 60 years | 12 | 0 | 0 | 3 | 10 | 0 | 1 |
a
Observations of behavioural patterns, health status of population following AYUSH measures and awareness about AYUSH measures for prevention and control.